Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
European Respiratory Journal Conference: European Respiratory Society International Congress, ERS ; 60(Supplement 66), 2022.
Article in English | EMBASE | ID: covidwho-2270958

ABSTRACT

The pulmonary limitations after COVID-19 are still not completely known. Lung function test (LFT) and 6-minute walk test (6MWT) are accessible and safe tests to access them. Aim(s): To evaluate the differences between non-severe and severe COVID-19 patients regarding LFT and 6MWT. Method(s): This study included patients with previous COVID-19 assessed in Pulmonology Department at 2 hospitals during 7 months who performed LFT and 6MWT. Baseline and immediately pos-6MWT heart rate (HR), SpO2, respiratory rate (RR) and perceived symptoms using a modified BORG scale were collected. We compared nonsevere and severe patients. Result(s): We included 151 patients, 69 (45.7%) with severe disease. LFT was performed 116.8+/-68.3days and the 6MWT 129.1+/-72.3days after COVID-19, without statistical difference between groups. We documented lower %FVC (94.4+/-14.7vs101.1+/-12.6%, p=0.003), %TLC (95.4+/-15.3vs107.1+/-12.3%, p=0.000) and %DLCO (68.8+/-16.5vs78.9+/-15.9%, p=0.000) in the severe group, without statistical differences in FEV1, FEV1/FVC and KCO. The 6MWT distance (m: 426.5+/-110.9vs498.2+/-93.5m, p=0.000;%:77.3+/-16.8%vs86.1+/-13.4%, p=0.001), estimated metabolic equivalents (3.03+/-0.5vs3.4+/-0.4, p=0.000) and minimal SpO2 (92.0+/-3.3vs93.8+/-3.1%, p=0.000) were lower in the severe group. The time spent below 90%SpO2 (5.6+/-19.4vs2.6+/-13.6%, p=0.039), %age-predicted maximal HR (68.5+/-10.5vs64.9+/-8.8%, p=0.023) and initial RR (19.1+/-5.1vs18.7+/-9.3 cpm, p=0.014) were higher. We did not document differences regarding the differential (maximal-initial) HR, final RR, differential (final-initial) RR and symptoms. Conclusion(s): Severe group showed higher functional limitation, mainly in lung volumes and in submaximal exercise evaluation.

2.
EMC - Anestesia-Rianimazione ; 27(4):1-9, 2022.
Article in English | ScienceDirect | ID: covidwho-2096181

ABSTRACT

Riassunto La valutazione respiratoria preoperatoria è un elemento importante della consulenza anestesiologica perché le complicanze respiratorie postoperatorie pesano tanto quanto le complicanze cardiovascolari sulla mortalità postoperatoria. La maggior parte di questa valutazione si basa su elementi accessibili mediante l’esame obiettivo. Gli esami complementari hanno un ruolo molto modesto a parte situazioni molto specifiche. Possono essere utilizzati diversi punteggi predittivi di complicanze al fine di fornire informazioni corrette al paziente e di argomentare le strategie di prevenzione delle complicanze postoperatorie. La generalizzazione di migliori protocolli riabilitativi dopo l’intervento chirurgico potrebbe ridurre l’incidenza complessiva delle complicanze respiratorie postoperatorie. Infine, l’infezione da severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) è associata a una morbilità significativa anche nei pazienti asintomatici. Quando possibile, dovrebbe essere eseguita la chirurgia programmata in pazienti asintomatici e la procedura deve essere posticipata di 7 settimane dopo un’infezione da SARS-CoV-2.

3.
EMC - Anestesia-Reanimación ; 48(4):1-10, 2022.
Article in English | ScienceDirect | ID: covidwho-2086866

ABSTRACT

Resumen La valoración respiratoria preoperatoria es un elemento importante de la consulta de anestesia, ya que las complicaciones respiratorias postoperatorias influyen en la mortalidad postoperatoria tanto como las complicaciones cardiovasculares. Lo esencial de esta valoración se basa en elementos accesibles a través de la exploración física. Las exploraciones complementarias ocupan un lugar muy modesto, al margen de situaciones muy específicas. Se pueden utilizar varias puntuaciones predictivas de complicaciones, para proporcionar una información honesta al paciente y argumentar las estrategias de prevención de las complicaciones postoperatorias. La generalización de los protocolos de rehabilitación mejorada después de la cirugía podría disminuir la incidencia global de complicaciones respiratorias postoperatorias. Por último, la infección por coronavirus 2 del síndrome respiratorio agudo grave (SARS-CoV-2) se acompaña de una morbilidad importante incluso en pacientes asintomáticos. Siempre que sea posible, la cirugía programada debe llevarse a cabo en pacientes asintomáticos y la intervención posponerse 7 semanas tras una infección por SARS-CoV-2.

SELECTION OF CITATIONS
SEARCH DETAIL